Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year : The main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-α. Results of the cml89 trial of the Spanish Collaborative Group on Interferon-α2a and CML

Bibliographische Detailangaben

Veröffentlicht in:	Haematologica (Roma) 1999-11, Vol.84 (11), p.978-987
Hauptverfasser:	STEEGMANN, J. L, ODRIOZOLA, J, LAVILLA, E, MIGUEL, A, AREAL, C, PEREZ-ENCINAS, M, ABAD, A, MALDONADO, J, MASSAGUE, I, FERNANDEZ-RANADA, J. M, RODRIGUEZ-SALVANES, F, GIRALDO, P, GARCIA-LARANA, J, FERRO, M. T, BENITEZ, E, PEREZ-PONS, C, GIRALT, M, ESCRIBANO, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Immunotherapy Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!